Marc Haniford

Thesis title: Investigating the Multifaceted Effects of DNA Damage Response Inhibitors on the Glioblastoma Microenvironment

Biography

Background

As a dedicated glioblastoma researcher, I am currently pursuing a PhD in Precision Medicine at the University of Glasgow and University of Edinburgh, funded by the Medical Research Council in partnership with AstraZeneca. My research focuses on understanding the role of the ATM inhibitor AZD1390 on microglial function, with the broader aim of uncovering novel therapeutic avenues for glioblastoma. With a strong background in experimental design, bioinformatics, and advanced imaging techniques, I’ve honed my expertise in translational radiobiology, particularly in troubleshooting complex research protocols. I am passionate about bridging the gap between basic research and clinical application, aiming to accelerate the translation of new discoveries into effective treatments for GBM. Through my PhD journey within the Precision Medicine Doctoral Training Partnership (DTP), I aim to further expand my expertise and contribute to the development of innovative strategies in cancer biology, driving progress in the fight against this devastating disease.

Qualifications

BSc (Hons) Microbiology with Specialism in Bacteriology, University of Glasgow

MRes Biomedical Sciences with Specialism in Cancer Studies, University of Glasgow

This article was published on